Cargando…

Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis

BACKGROUND: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamlin, Matilda, Holmén, Joacim, Wentz, Elisabet, Aiff, Harald, Ali, Lilas, Steingrimsson, Steinn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600645/
https://www.ncbi.nlm.nih.gov/pubmed/37819697
http://dx.doi.org/10.2196/48843
_version_ 1785126031764488192
author Hamlin, Matilda
Holmén, Joacim
Wentz, Elisabet
Aiff, Harald
Ali, Lilas
Steingrimsson, Steinn
author_facet Hamlin, Matilda
Holmén, Joacim
Wentz, Elisabet
Aiff, Harald
Ali, Lilas
Steingrimsson, Steinn
author_sort Hamlin, Matilda
collection PubMed
description BACKGROUND: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, improve symptoms of depression, and reduce health care resource use. OBJECTIVE: The aim of this study was to determine patients’ experience of digitalized follow-up using a mobile app as an adjunct to treatment concurrent with a new prescription, a change of antidepressant, or a dose increase. METHODS: This was a qualitative, descriptive study. Patients at 2 psychiatric outpatient clinics were recruited at the time of changing antidepressant medication. After using a mobile app (either a commercial app or a public app) for 4-6 weeks with daily registrations of active data, such as medical intake and questions concerning general mental health status, individual semistructured interviews were conducted. Recorded data were transcribed and then analyzed using content analysis. RESULTS: In total, 13 patients completed the study. The mean age was 35 (range 20-67) years, 8 (61.5%) were female, and all reported high digital literacy. Overall, the emerging themes indicated that the patients found the digital app to be a valuable adjunct to antidepressant treatment but with potential for improvement. Both user adherence and medical adherence were positively affected by a daily reminder and the app’s ease of use. User adherence was negatively affected by the severity of depression. The positive experience of visually presented data as graphs was a key finding, which was beneficial for self-awareness, the patient-physician relationship, and user adherence. Finally, the patients had mixed reactions to the app’s content and requested tailored content. CONCLUSIONS: The patients identified several factors addressing both medical adherence and user adherence to a digital app when using it for digitalized follow-up concurrent with the critical time related to changes in antidepressant medication. The findings highlight the need for rigorous evidence-based empirical studies to generate sustainable research results.
format Online
Article
Text
id pubmed-10600645
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-106006452023-10-27 Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis Hamlin, Matilda Holmén, Joacim Wentz, Elisabet Aiff, Harald Ali, Lilas Steingrimsson, Steinn JMIR Ment Health Original Paper BACKGROUND: Nonadherence to pharmaceutical antidepressant treatment is common among patients with depression. Digitalized follow-up (ie, self-monitoring systems through mobile apps) has been suggested as an effective adjunct to conventional antidepressant treatment to increase medical adherence, improve symptoms of depression, and reduce health care resource use. OBJECTIVE: The aim of this study was to determine patients’ experience of digitalized follow-up using a mobile app as an adjunct to treatment concurrent with a new prescription, a change of antidepressant, or a dose increase. METHODS: This was a qualitative, descriptive study. Patients at 2 psychiatric outpatient clinics were recruited at the time of changing antidepressant medication. After using a mobile app (either a commercial app or a public app) for 4-6 weeks with daily registrations of active data, such as medical intake and questions concerning general mental health status, individual semistructured interviews were conducted. Recorded data were transcribed and then analyzed using content analysis. RESULTS: In total, 13 patients completed the study. The mean age was 35 (range 20-67) years, 8 (61.5%) were female, and all reported high digital literacy. Overall, the emerging themes indicated that the patients found the digital app to be a valuable adjunct to antidepressant treatment but with potential for improvement. Both user adherence and medical adherence were positively affected by a daily reminder and the app’s ease of use. User adherence was negatively affected by the severity of depression. The positive experience of visually presented data as graphs was a key finding, which was beneficial for self-awareness, the patient-physician relationship, and user adherence. Finally, the patients had mixed reactions to the app’s content and requested tailored content. CONCLUSIONS: The patients identified several factors addressing both medical adherence and user adherence to a digital app when using it for digitalized follow-up concurrent with the critical time related to changes in antidepressant medication. The findings highlight the need for rigorous evidence-based empirical studies to generate sustainable research results. JMIR Publications 2023-10-11 /pmc/articles/PMC10600645/ /pubmed/37819697 http://dx.doi.org/10.2196/48843 Text en ©Matilda Hamlin, Joacim Holmén, Elisabet Wentz, Harald Aiff, Lilas Ali, Steinn Steingrimsson. Originally published in JMIR Mental Health (https://mental.jmir.org), 11.10.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Mental Health, is properly cited. The complete bibliographic information, a link to the original publication on https://mental.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Hamlin, Matilda
Holmén, Joacim
Wentz, Elisabet
Aiff, Harald
Ali, Lilas
Steingrimsson, Steinn
Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
title Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
title_full Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
title_fullStr Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
title_full_unstemmed Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
title_short Patient Experience of Digitalized Follow-up of Antidepressant Treatment in Psychiatric Outpatient Care: Qualitative Analysis
title_sort patient experience of digitalized follow-up of antidepressant treatment in psychiatric outpatient care: qualitative analysis
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600645/
https://www.ncbi.nlm.nih.gov/pubmed/37819697
http://dx.doi.org/10.2196/48843
work_keys_str_mv AT hamlinmatilda patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis
AT holmenjoacim patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis
AT wentzelisabet patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis
AT aiffharald patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis
AT alililas patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis
AT steingrimssonsteinn patientexperienceofdigitalizedfollowupofantidepressanttreatmentinpsychiatricoutpatientcarequalitativeanalysis